These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1486148)

  • 1. Multidiagnostic evaluation of prolactin response to haloperidol challenge in schizophrenia: maximal blunting in Kraepelinian patients.
    Keks NA; McKenzie DP; Low LH; McGorry PD; Hill C; Kulkarni J; Singh BS; Copolov DL
    Biol Psychiatry; 1992 Sep; 32(5):426-37. PubMed ID: 1486148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
    Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
    Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal and haloperidol-stimulated prolactin and symptoms of nonaffective and affective psychoses in neuroleptic-free men.
    Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hill C; Hope JD; Singh BS
    Biol Psychiatry; 1995 Feb; 37(4):229-34. PubMed ID: 7711159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
    Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
    Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T; Marder SR; Mintz J
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
    Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
    Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin bioassay in schizophrenia before and after neuroleptics.
    Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
    Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
    Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
    Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.
    Markianos M; Sakellariou G; Bistolaki E
    J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men.
    Rubin RT; Hays SE
    Psychopharmacology (Berl); 1979 Mar; 61(1):17-24. PubMed ID: 108715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prolactinemia and predictability of therapeutic response of schizophrenic patients in acute decompensation].
    Vanelle JM; Amorim P; Piketti ML; Bourdel MC; Poirier-Littré MF
    Encephale; 1996 Oct; 22 Spec No 3():82-4. PubMed ID: 8954284
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of haloperidol on aldosterone secretion.
    Warner MD; Gillespie H; Pavlou SN; Nader S; Peabody CA
    Psychoneuroendocrinology; 1992 Oct; 17(5):517-21. PubMed ID: 1484918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
    Copolov DL; Keks NA; Kulkarni J; Singh BS; McKenzie D; McGorry P; Hill C
    Psychoneuroendocrinology; 1990; 15(3):225-31. PubMed ID: 2255750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol treatment on serum prolactin level in schizophrenic patients.
    Elizur A; Segal Z; Yeret A; Ben-David M
    Commun Psychopharmacol; 1980; 4(3):203-6. PubMed ID: 7226751
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal prolactin response to haloperidol challenge in men with schizophrenia.
    Keks NA; Copolov DL; Singh BS
    Am J Psychiatry; 1987 Oct; 144(10):1335-7. PubMed ID: 3661768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
    Möller HJ; Kissling W; Lang C; Doerr P; Pirke KM; von Zerssen D
    Am J Psychiatry; 1982 Dec; 139(12):1571-5. PubMed ID: 7149056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
    Kirkpatrick B; Carpenter WT; Maeda K; Buchanan RW; Breier A; Tamminga CA
    Biol Psychiatry; 1992 Dec; 32(11):1049-54. PubMed ID: 1467385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment with various doses of haloperidol on the pituitary-gonadal axis in male schizophrenic patients.
    Rinieris P; Hatzimanolis J; Markianos M; Stefanis C
    Neuropsychobiology; 1989; 22(3):146-9. PubMed ID: 2485861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.